Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06924463 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry

Study acronym: AERO-RMS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 11, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Lille University
8 trials monitored
See all monitored trials
Sarcoma
1,026 trials monitored
See 67 trials at risk
This non-interventional study aims to develop spatial proteomics for analyzing small FFPE tumor samples in rhabdomyosarcoma. It will identify molecular signatures linked to tumor regions, subtypes, survival, and treatment resistance, using pre-existing samples and data.
Trial Details
NCT Number NCT06924463
Lead Sponsor Lille University
Collaborators: Centre Oscar Lambret, Lille, France
Conditions
(from sponsor)		 Rhabdomyosarcoma
Related terms Rhabdomyosarcoma
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov